Frontiers in Oncology | Breast Cancer

Systematic Review

Published on 13 Oct 2023

Hepatitis C virus infection is associated with high risk of breast cancer: a pooled analysis of 68,014 participants

in Breast Cancer

Haiping Chen
Pei Du
Tianyao Yang
Xueyuan Xu
Tianyang Cui
Yuhang Dai

Frontiers in Oncology

doi 10.3389/fonc.2023.1274340

2,641 views

Original Research

Published on 12 Oct 2023

Intra-tumoral microbial community profiling and associated metabolites alterations of TNBC

in Breast Cancer

Yi Wang
Dingding Qu
Yali Zhang
Yiping Jin
Yu Feng
He Zhang
Qingxin Xia

Frontiers in Oncology

doi 10.3389/fonc.2023.1143163

4,591 views
7 citations

Original Research

Published on 12 Oct 2023

Health-related quality of life and patient-centred outcomes with COVID-19 vaccination in patients with breast cancer and gynaecological malignancies

in Breast Cancer

Marie Forster
Rachel Wuerstlein
Alexander Koenig
Alexandra Stefan
Elisa Wiegershausen
Falk Batz
Fabian Trillsch
Sven Mahner
Nadia Harbeck
Anca Chelariu-Raicu

Frontiers in Oncology

doi 10.3389/fonc.2023.1217805

2,178 views

Review

Published on 12 Oct 2023

Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer

in Breast Cancer

Junyuan Xie
Li Gan
Bingjian Xue
Xinxing Wang
Xinhong Pei

Frontiers in Oncology

doi 10.3389/fonc.2023.1264090

2,763 views
8 citations

Review

Published on 11 Oct 2023

Research progress of Claudin-low breast cancer

in Breast Cancer

Chenglong Pan
Anqi Xu
Xiaoling Ma
Yanfei Yao
Youmei Zhao
Chunyan Wang
Ceshi Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1226118

5,617 views
13 citations

Systematic Review

Published on 10 Oct 2023

Global epidemiology of breast cancer based on risk factors: a systematic review

in Breast Cancer

Amna Roheel
Aslam Khan
Fareeha Anwar
Zunaira Akbar
Muhammad Furqan Akhtar
Mohammad Imran Khan
Mohammad Farhan Sohail
Rizwan Ahmad

Frontiers in Oncology

doi 10.3389/fonc.2023.1240098

19,068 views
41 citations

Original Research

Published on 09 Oct 2023

Endocrine treatment near the end of life among older women with metastatic breast cancer: a nationwide cohort study

in Breast Cancer

Máté Szilcz
Jonas W. Wastesson
Amaia Calderón-Larrañaga
Lucas Morin
Henrik Lindman
Kristina Johnell

Frontiers in Oncology

doi 10.3389/fonc.2023.1223563

1,926 views

Original Research

Published on 06 Oct 2023

Abscopal effect in metastatic breast cancer treated with stereotactic body radiotherapy in the absence of immunotherapy

in Breast Cancer

Jae Sik Kim
Ah Ram Chang

Frontiers in Oncology

doi 10.3389/fonc.2023.1243053

2,438 views
3 citations

Review

Published on 04 Oct 2023

Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer

in Breast Cancer

Hongsheng Zhang
Jintao Mi
Qi Xin
Weiwei Cao
Chunjiao Song
Naidan Zhang
Chengliang Yuan

Frontiers in Oncology

doi 10.3389/fonc.2023.1256360

5,530 views
11 citations

Original Research

Published on 04 Oct 2023

Age has a U-shaped relationship with breast cancer outcomes in women: a cohort study

in Breast Cancer

Yujie Xie
Yongqing Deng
Suosu Wei
Zhen Huang
Lihui Li
Kai Huang
Chunyu Wei
Jinan Xu
Lingguang Dong
Qiuhuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1265304

2,436 views
5 citations

Review

Published on 04 Oct 2023

Treatment options for patients with hormone receptor-positive, HER2-negative advanced-stage breast cancer: maintaining cyclin-dependent kinase 4/6 inhibitors beyond progression

in Breast Cancer

Malek Horani
Hikmat Abdel-Razeq

Frontiers in Oncology

doi 10.3389/fonc.2023.1272602

3,675 views
1 citation

Original Research

Published on 03 Oct 2023

Trends in research of exosomes associated with breast cancer over the past decade: a scientometric analysis

in Breast Cancer

Jiaxin Wu
Daitian Zheng
Haiting Wang
Zhongming Zhou
Qiuping Yang
Jinyao Wu
Huiting Tian
Zeqi Ji
Lingzhi Chen
Jiehui Cai

Frontiers in Oncology

doi 10.3389/fonc.2023.1273555

3,031 views
1 citation

Review

Published on 03 Oct 2023

Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress

in Breast Cancer

Yushi Chen
Yu Qi
Kuansong Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1169010

6,424 views
16 citations

Original Research

Published on 02 Oct 2023

Real-world patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancer

in Breast Cancer

Peter A. Kaufman
Edward Neuberger
Naomi R. M. Schwartz
Shu Wang
Yutong Liu
Ling-I Hsu
Karen Bartley
Matthew T. Blahna
Brian T. Pittner
Gabriel Wong

Frontiers in Oncology

doi 10.3389/fonc.2023.1264861

7,385 views
6 citations

Original Research

Published on 02 Oct 2023

Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study

in Breast Cancer

Joon Young Choi
Doyoun Woen
Sung Yoon Jang
Hyunjun Lee
Dong Seung Shin
Youngji Kwak
Hyunwoo Lee
Byung Joo Chae
Jonghan Yu
Jeong Eon Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1230310

10,244 views
2 citations

Original Research

Published on 02 Oct 2023

Questionnaire study of application about sentinel lymph node biopsy surgery in locally advanced breast cancer patients who received neoadjuvant chemotherapy

in Breast Cancer

Eun-Gyeong Lee
Minjung Lee
So-Youn Jung
Jai Hong Han
Seok-Ki Kim
Seeyoun Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1235938

1,268 views
1 citation